Nexavar® (sorafenib) Tablets

Given Nexavar’s efficacy in two difficult-to-treat cancers, we, together with our partner Bayer, are implementing a broad clinical development program designed to access Nexavar’s applicability across multiple tumor types, including breast, colorectal, lung, and ovarian cancers, and as an adjuvant therapy for liver and kidney cancer.